HEMOCHRON JR. MICROCOAGULATION ACT PLUS TEST JACT+

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2015-08-12 for HEMOCHRON JR. MICROCOAGULATION ACT PLUS TEST JACT+ manufactured by Accriva Diagnostics.

Event Text Entries

[24944474] This mdr submitted on 08/12/2015 references accriva complaint number (b)(4). The serial number of the hemochron signature elite instrument used during this procedure and reported as a child under this mdr is (b)(4) and references accriva complaint number (b)(4). Process evaluation of the hemochron signature elite instrument associated with this complaint was performed and no ncmrs or anomalies were identified. Accriva has requested all data required for form 3500a. Fields for which data were not obtainable or are not applicable are intentionally left blank.
Patient Sequence No: 1, Text Type: N, H10


[24944475] Healthcare professional reported out of range high readings with a hemochron signature elite and act plus system. A (b)(6) male patient was receiving iv heparin while on cardiovascular bypass during an unspecified interventional cardiology procedure. The target act was not specified. The hemochron signature elite and act plus system reported one act result greater than 1005 seconds (out of range high). An act test was repeated immediately and the result was 506 seconds, which was as expected. The procedure continued and a subsequent act measured with the same hemochron signature elite and act plus system after protamine was administered was 136 seconds. The heparin doses administered and the act results reported during the case are summarized in section. Both electronic and liquid quality controls passed. The procedure was completed successfully and no patient injury or adverse events were reported.
Patient Sequence No: 1, Text Type: D, B5


[73855745] This mdr follow-up #1 submitted on 10/22/2015. References accriva complaint number (b)(4). This report provides the results of lsr 15-048, which attempted to reproduce the customer complaint with this cuvette lot of jact+. Reserve sample tested from same lot, no failure detected. Whole blood samplers from three normal donors were tested at final heparin concentrations of 0, 3. 3 and 5. 0 units/ml with 10 replicates.
Patient Sequence No: 1, Text Type: N, H10


[73855746] Follow-up #1.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3002721930-2015-00002
MDR Report Key5004129
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2015-08-12
Date of Report2015-07-24
Date of Event2015-07-24
Date Mfgr Received2015-10-20
Device Manufacturer Date2015-06-01
Date Added to Maude2015-08-14
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJON MCDERMED
Manufacturer Street6260 SEQUENCE DR
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal92121
Manufacturer Phone8582632490
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameHEMOCHRON JR. MICROCOAGULATION ACT PLUS TEST
Generic NameTEST, TIME, ACTIVATED CLOTTING TIME
Product CodeJBP
Date Received2015-08-12
Model NumberJACT+
Catalog NumberJACT+
Lot NumberF5JAC540
Device Expiration Date2016-09-30
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerACCRIVA DIAGNOSTICS
Manufacturer AddressSAN DIEGO CA 92128 US 92128


Patients

Patient NumberTreatmentOutcomeDate
10 2015-08-12

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.